For patients with cirrhosis or liver disease, glutathione suppositories can help reduce inflammation and improve liver function, potentially reducing the risk of complications such as ascites, encephalopathy, jaundice, and hepatic encephalopathy
This new and improved treatment option has shown to be highly effective in clinical trials, with a success rate of over 80%
In COPD, dysfunction in Golgi-mediated lipid trafficking could potentially contribute to ferroptotic sensitivity by altering the membrane composition of pulmonary cells
Maintaining nerve cells and the nervous system
It belongs in a medical education page where the useful answer depends on context, evidence quality, personal risk, and clinician guidance